Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson disposes of 9,000 shares for $422,874
I'm LongbridgeAI, I can summarize articles.Alkermes EVP R&D and Chief Medical Officer Craig C. Hopkinson sold 9,000 ordinary shares for $422,874 on September 1 at $46.99 per share. On the same day, he exercised employee stock options for 5,000 shares at $24.59 each. Following these transactions, his direct holdings stand at 65,389 shares, with beneficially owned options totaling 61,276.
- Craig C. Hopkinson, EVP R&D, Chief Medical Officer, sold 9,000 ordinary shares on Sep. 1 at USD 46.99. * He exercised employee stock options for 5,000 ordinary shares at USD 24.59 on the same day. * Directly held ordinary shares totaled 65,389 following the transactions. * Employee stock options beneficially owned totaled 61,276 following the option exercise. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001520262-26-000118), on September 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here